ArticleFrontiers in public health2025
Utility of compartmental models to test the competing hypotheses of pathogen evolution and human intervention.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Compartmental models are essential for studying host-pathogen dynamics, evaluating intervention effectiveness, and predicting infection trends. However, the utility of these models for testing competing hypotheses is often overlooked. To address this, we propose a new model-based hypothesis testing (MBHT) approach, which uses compartmental models to evaluate the hypotheses in epidemiology. In our case, using the COVID-19 pandemic as a case study, we formulate hypotheses of SARS-CoV-2 mutation and construct a transmission model to test them. In addition to analyzing steady-state stability, deriving the basic reproduction number, and identifying a backward bifurcation, the model is fitted to seven peaks of U.S. COVID-19 data, each corresponding to periods of viral mutation and morbidity peaks. The estimated posterior probabilities reveal that Short-term within host selection primarily shaped mutations during the early pandemic stages, followed by immune selection driven by natural and vaccine-induced immunity. In later stages, mutations aligned with vaccination-induced virulence and transmission-virulence correlation, while the declining virulence and immune selection partially explained the final stages of SARS-CoV-2 mutation. In conclusion, model-based hypothesis testing offers a powerful yet underutilized approach to uncovering drivers of viral mutation and gaining deeper insights into pathogen evolution during outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.